Skip to content
Companies

DeepkinetiX

AI pharmacokinetic modeling for drug dosing

Raised to date

$1M

of $2.5M offered across 1 Form D filing

Still open
$1.5M
Investors
1
Last filed
Mar 13, 2025

About

DeepkinetiX Inc. is a pioneering company dedicated to revolutionizing the drug development landscape through the innovative application of artificial intelligence and computational modeling techniques. By employing advanced technologies, they strive to optimize pharmacokinetic and pharmacodynamic processes, fostering speed and precision in drug analysis.

DeepkinetiX stands out by leveraging patient-derived data for enhanced accuracy in predictive modeling, aiming to minimize animal testing and improve drug development outcomes.

Funding

  • Option to acquireFiled Mar 13, 2025Form D
    $1M/ $2.5M

Product

KinetixFlow™

Software Platform

KinetixFlow™ is an advanced AI-powered software platform specifically designed for pharmacokinetic and pharmacodynamic analysis. It integrates complex algorithms to analyze extensive data sets, predicting how drugs will behave in the human body and significantly optimizing dosing strategies.

  • AI-driven predictive analytics
  • Real-time pharmacokinetic/pharmacodynamic modeling
  • Enhanced accuracy with patient-derived cellular data

Built for

Pharmaceutical and Biotechnology Companies

People on file